Cognitive Remediation to Improve Mobility in Sedentary Seniors
CREM
Cognitive Intervention to Improve Simple and Complex Walking
2 other identifiers
interventional
383
1 country
1
Brief Summary
The investigators propose to conduct a single-blind randomized clinical trial to test the efficacy of a computerized cognitive remediation intervention program on improving locomotion in sedentary seniors, a group at an especially high risk for disability. The hypothesis is that executive functions will respond to the cognitive remediation program and in turn enhance locomotion.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2016
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 17, 2015
CompletedFirst Posted
Study publicly available on registry
October 2, 2015
CompletedStudy Start
First participant enrolled
March 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2020
CompletedResults Posted
Study results publicly available
June 7, 2021
CompletedFebruary 28, 2024
February 1, 2024
4.3 years
August 17, 2015
March 15, 2021
February 22, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Change in Walking Speed During Single and Dual-task Conditions.
Between group difference in change per arm of gait speed (centimeters/second) measured during normal pace walking and walking while talking conditions using an instrumented walkway (GAITRite® electronic walkway system).
Baseline and 2 months
Secondary Outcomes (15)
Change in Short Physical Performance Battery (SPPB).
Baseline and 2 months
Stride Length.
Baseline and 2 months
Gait Variability.
Baseline and 2 months
Variability in Gait Domains
Baseline and 2 Months
Number of Participants With Substantial Gait Speed Change.
Baseline and 2 Months
- +10 more secondary outcomes
Other Outcomes (9)
The Geriatric Depression Scale (GDS).
Baseline and 2 months
Rosenberg Self-Esteem Scale.
Baseline and 2 months
Falls Efficacy Scale.
Baseline and 2 months
- +6 more other outcomes
Study Arms (2)
Cognitive Remediation
EXPERIMENTALAn individualized computerized cognitive remediation program.
Active control
ACTIVE COMPARATORIndividualized computer based exposure and interactive health education classes.
Interventions
This computerized program has successfully been used by seniors in different settings. It trains a number of cognitive processes including attention and Executive Function.The Cognitive Remediation (CREM) training is constructed based on the program's built in baseline cognitive evaluation.
Eligibility Criteria
You may qualify if:
- Adults aged 70 and older, residing in the community.
- Plan to be in area for next year.
- Able to speak English at a level sufficient to undergo our cognitive assessment battery.
- Ambulatory. Subjects are classified as 'non-ambulatory' if they are unable to leave the confines of their home and attend a clinic visit.
- Gait velocity ≤1 m/s.
- Short Physical Performance Battery score ≤9.
You may not qualify if:
- Presence of dementia identified by any one of the following: Telephone based Memory Impairment Screen score (T-MIS) of \<5, Alzheimer's Disease 8 (AD8) ≥ 2. Or dementia diagnosed by baseline cognitive assessment.
- Serious chronic or acute illness such as cancer (late stage, metastatic, or on active treatment), chronic pulmonary disease on ventilator or continuous oxygen therapy or active liver disease.
- Mobility limitations solely due to musculoskeletal limitation or pain (e.g., severe osteoarthritis) that prevent subjects from completing mobility tests. Presence of arthritis will not be used to exclude subjects if they can complete the mobility tasks.
- Any medical condition or chronic medication use (e.g., neuroleptics) that will compromise safety or affect cognitive functioning or terminal illness with life expectancy less than 12 months.
- Presence of progressive, degenerative neurologic disease (e.g., Parkinson's disease or ALS).
- Hospitalized in the past 6 months for severe illness or surgery that specifically affects mobility (e.g. hip or knee replacement) and that prevent subjects from completing mobility tests or plans for surgery affecting mobility in the next 6 months.
- Severe auditory or visual loss.
- Active psychoses or psychiatric symptoms (such as agitation) noted during the clinic visit that will prevent completion of study protocols.
- Living in nursing home.
- Participation in other intervention trial or observational studies. -
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Albert Einstein College of Medicine
The Bronx, New York, 10461, United States
Related Publications (3)
Verghese J, Mahoney J, Ambrose AF, Wang C, Holtzer R. Effect of cognitive remediation on gait in sedentary seniors. J Gerontol A Biol Sci Med Sci. 2010 Dec;65(12):1338-43. doi: 10.1093/gerona/glq127. Epub 2010 Jul 19.
PMID: 20643703RESULTVerghese J, Mahoney JR, Ayers E, Ambrose A, Wang C, Holtzer R. Computerised cognitive remediation to enhance mobility in older adults: a single-blind, single-centre, randomised trial. Lancet Healthy Longev. 2021 Sep;2(9):e571-e579. doi: 10.1016/s2666-7568(21)00173-2. Epub 2021 Sep 2.
PMID: 34522910DERIVEDVerghese J, Ayers E, Mahoney JR, Ambrose A, Wang C, Holtzer R. Cognitive remediation to enhance mobility in older adults: the CREM study. Neurodegener Dis Manag. 2016 Dec;6(6):457-466. doi: 10.2217/nmt-2016-0034. Epub 2016 Nov 4.
PMID: 27813452DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Joe Verghese
- Organization
- Albert Einstein College of Medicine
Study Officials
- PRINCIPAL INVESTIGATOR
Joe Verghese, MD
Albert Einstein College of Medicine
- PRINCIPAL INVESTIGATOR
Roee Holtzer, PhD
Albert Einstein College of Medicine
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 17, 2015
First Posted
October 2, 2015
Study Start
March 1, 2016
Primary Completion
June 1, 2020
Study Completion
August 1, 2020
Last Updated
February 28, 2024
Results First Posted
June 7, 2021
Record last verified: 2024-02